// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Widespread compartmentalization of glucocorticoid physiology during mouse development

Adam W Plumb - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

ROLE OF ADRENAL PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN GLUCOCORTICOID-MEDIATED FETAL PROGRAMMING OF HYPERTENSION

Phong Nguyen - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

Glucocorticoid

Hair Cortisol Concentrations in Patients with Obstructive Sleep Apnea

Gideon Koren - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Effectiveness and Safety of Outpatient Alpha and Beta Blockade Titration Protocol in Pheochromocytoma

Daryl Gray - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pheochromocytomas and paragangliomas

Phenoxybenzamine

BA058, a Novel Human PTHrP Analog, Restores Bone Density and Increases Bone Strength At the Spine and Femur in Osteopenic Rats

Elisabeth Lesage - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

BA-058

Tumour Induced Osteomalacia due to a Hemangiopericytoma

Sophie Jamal - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemangiopericytoma

Octreotide

Vitamin D supplementation in women is regulated by 24 hydroxylation of serum 25 hydroxyvitamin D

Glenville Jones - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Parathyroid hormone

A High Sensitivity Analytical Method for the Determination of Derivatized 1,25-Dihydroxyvitamin D3 and 1,25-Dihydroxyvitamin D2 by LC/MS/MS

Adam Latawiec - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

High Throughput Analysis of 25-OH-Vitamin D using Micro-flow LC/MS/MS

Evelyn L McClure - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

cholecalciferol

Vitamin D Supplementation Protocol in Osteoporosis: Chart Review

Sandra Ann Kim - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Nephrolithiasis, calcium oxalate

Teriparatide

Progesterone-induced stimulation of PR-positive murine mammary tumorigenesis is due to the progesterone metabolite, 5alpha-dihydroprogesterone (5aP)

Roxana Schillaci - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Finasteride

FGFR2 Signaling Provides an Alternate Mode of Her2/Neu Activation in Breast Cancer

Wei Liu - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Trastuzumab

Efficacy of differing lipid-lowering management strategies in patients with a history of statin-related myopathy

Tisha Joy - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cap myopathy

Atorvastatin

Adrenal Vein Sampling: Rethinking the use of Cortisol for Selectivity Index Calculations. Results of Mulitplex Analysis of 6 Adrenal Steroids

Daniel Thomas Holmes - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary aldosteronism

N/A

Simvastatin but not ezetimibe upregulates circulating PCSK9 levels: Evidence from a randomised trial

Heiner Berthold - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ezetimibe and simvastatin

Diabetes-associated lipoprotein-induced monocyte adhesion: involvement of plasminogen activator inhibitor-1

Song Ren - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

ICAM-1

Placental lactogens regulate maternal glucose homeostasis during pregnancy

Saara Rawn - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

betaine

Postpartum Lifestyle Intervention in Women with Gestational Diabetes Mellitus: a pilot feasibility study

Jennifer Price - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Impact of Preconception Counseling On Awareness and Pregnancy Planning Among Women With Pregestational Diabetes

Julie Lee - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pregestational diabetes

N/A

Antepartum Predictors of Insulin Therapy and Type 2 Diabetes Development in Women with Gestational Diabetes Mellitus

Lena Salgado - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Copyright © 2026. QuantiNova All rights reserved